Abstract:Background: The number of the applications of bismuth (Bi) is rapidly and remarkably increasing, enhancing the chance to increase the levels to which humans are normally daily exposed. The interest to Bi comes also from the potential of Bi-based nanoparticles (BiNPs) for industrial and biomedical purposes. Like other metal-based NPs used in nanomedicine, BiNPs may release ultratrace amounts of Bi ions when injected. The metabolic fate and toxicity of these ions still needs to be evaluated. At present, knowledge of Bi metabolism in laboratory animals refers almost solely to studies under unnatural "extreme" exposures, i.e. pharmacologically relevant high-doses (up to thousand mg kg-1) in relation to its medical use, or infinitesimal-doses (pg kg-1 as non-carrier-added Bi radioisotopes) for radiobiology protection, diagnostic and radiotherapeutic purposes. No specific study exists on the "metabolic patterns" in animal models exposed to levels of Bi, i.e. at "environmental dose exposure" that reflect the human daily exposure (μg kg-1). Methodology: Rats were intraperitoneally injected with 0.8 μg Bi kg-1 bw as 205+206Bi(NO)3 alone or in combination with 59Fe for radiolabelling of iron proteins. The use of 205+206Bi radiotracers allowed the detection and measurement down to pg fg-1 of the element in the blood biochemical compartments and protein fractions as isolated by differential centrifugation, size exclusion- and ion exchange chromatography, electrophoresis, solvent extraction, precipitation and dialysis. Results: 24 h after the administration, the blood concentration of Bi was 0.18 ng mL-1, with a repartition plasma/red blod cells (RBC) in a ratio of 2:1. Elution profiles of plasma from gel filtration on Sephadex G-150 showed four pools of Bi-binder proteins with different molecular sizes (> 300 kDa, 160 kDa, 70 kDa and < 6.5 kDa). In the 70 kDa fraction transferrin and albumin were identified as biomolecule carriers for Bi. In red blood cells, Bi was distributed between cytosol and membranes (ghosts) in a ratio of about 5:1. In the cytosol, low molecular components (LMWC) and the hemoglobin associated the Bi in a ratio of about 1.8:1. In the hemoglobin molecule, Bi was bound to the beta polypeptide chain of the globin. In the ghosts, Bi was detected at more than one site of the protein fraction, with no binding with lipids. Dialysis experiments and the consistently high recovery (80-90 %) of 206Bi from chromatography of 206Bi-containing biocomponents suggest that Bi was firmly complexed at physiological pH with a low degree of breaking during the applications of experimental protocols for the isolation of the 206Bi-biocomplexes. These latter were sensitive to acid buffer pH 5, and to the presence of complexing agents in the dialysis fluid. Conclusions: On the basis of an environmental biochemical toxicology approach, we have undertaken a study on the metabolic patterns of Bi3+ ions in rats at tissue, subcellular and molecular level with the identification of cellular Bi-binding components. As a first part of the study the present work reports the results concerned with the metabolic fate of ultratrace levels of 205+206Bi(NO)3 in the blood.

Effect of S186 for decoporated radiostrontium compared with BADE in rats

Effect of low doses of S186 in removing strontium in rats and dogs

Biodistribution of 188Re-Aedp in Rats and Its Dependenceon Rhenium Carrier

Preparation of (188re) Re-AEDP and Its Biodistribution Studies.

[Effect of Adriamycin on Sarcoplasmic Reticulum Ca2+ -Atpase Activity in Cardiomyocyte of Rabbits]

Decorporating Efficacy of Catecholaminocarboxylate Chelating Agents for Thorium-234 and Protective Effects on Associated Radiation Injury.

[Therapeutic effect of aqueous-extract from a traditional Chinese medical herb Drynaria fortunei on rat experimental model of alveolar bone resorption].

Impact of Co-Exposure with Lead and Decabromodiphenyl Ether (BDE-209) on Thyroid Function in Zebrafish Larvae.

Neurobehavioral assessment of BMEDA by modified Irwin test in Sprague-Dawley rats

Studies of the effect of bone metabolism and bone mineral injury in rats intramuscularly injected with depleted uranium

Difficulty in dislodging in vivo fixed radiostrontium

[Effect of the chelator BPCBG on the decorporation of uranium in vivo and uranium-induced damage of human renal tubular epithelial cells in vitro]

Absorption, Distribution, Metabolism, and Excretion of [14C]BS1801, a Selenium-Containing Drug Candidate, in Rats

Effect of dexamethasone and phentolamine on pulmonary edema in mice caused by injection of an overdose of adrenaline

Effect of decabromodiphenyl ether (BDE-209) on a soil-biota system: Role of earthworms and ryegrass

Effect of 188Re-HEDP on the osteoblasts: proliferation, differentiation and apoptosis

EFFECT OF ALPHA-CALCIFEROL ON BONE MINERAL DENSITY, BONE HISTOMORPHOMETRY AND BONE BIOMECHANICS IN RATS BY RADIATIVE INJURY TO KIDNEY

Absorption, Distribution, Metabolism, and Excretion of [<SUP>14</SUP>C]BS1801, a Selenium-Containing Drug Candidate, in Rats

Dose-Dependent Disposition of Sodium Arsenate in Mice Following Acute Oral Exposure

Metallobiochemistry of ultratrace levels of bismuth in the rat I. Metabolic patterns of 205+206Bi3+ in the blood

The Chelator BPCBG Decorporates Uranium and Protects Against Uranium-Induced Kidney Injury in Rats